Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

February’s full Snow Moon set to rise in Ontario

February 1, 2026

Mutuum Finance (MUTM) Raises Over $20.2M as 19,000 Investors Are Testing The V1 Protocol Launch

February 1, 2026

Global Liver Institute’s Fifth #RareAware Campaign Puts Early Detection at the Center of Care

February 1, 2026

Mutuum Finance (MUTM) Surpasses $20 Million in Funding Following Launch of Its V1 Protocol on Sepolia Testnet

February 1, 2026

Barkmeta Provides Timely Analysis on Gold and Silver Amid Market Volatility

February 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
Press Release

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

By News RoomNovember 24, 20234 Mins Read
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
Share
Facebook Twitter LinkedIn Pinterest Email
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) — Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder (either before or after these batch codes) and no other Ting® Antifungal Spray products are in the scope of this recall and may continue to be used by consumers safely and as intended.

Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it potentially can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life threatening. Insight is recalling these products out of an abundance of caution. To date, the Company has not received any serious adverse events related to this recall. Benzene is ubiquitous in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources.

TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder is packaged in green and white aerosol cans with Lot codes located on the bottom of the can.

Samples of the recalled lots below have been found to contain trace levels of Benzene related to the propellant that sprays the product out of the can. Benzene is not an ingredient in any Ting products.

  Product   NDC   Lot Code   Expiration   Package Size
  TING 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder   63736-532-05   0H88645   07/24   4.5 oz/128 g
  TING 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder   63736-532-05   0B88345   02/24   4.5 oz/128 g
 

The affected TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder lots were distributed nationwide in the United States through a limited number of retailers and online.

Insight has notified retailers via overnight mail to remove any remaining recalled product from shelves and follow the instructions provided in the Drug Recall Notification. The company will also offer reimbursement for consumers who have purchased TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray marked with one of the lot codes in the table above. Consumers can contact Insight Pharmaceuticals via e-mail at [email protected], through its website at https://www.prestigebrands.com/contact, or by phone at (800) 344-7239 on Monday – Friday 8:30-5:30 eastern time to receive a full refund by providing a picture of the bottom of the can of the TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray with the affected lot number. Consumers that have product which is being recalled should stop using the product immediately and appropriately discard after taking the picture.

No serious adverse events have been reported to date.

Consumers with questions regarding this recall can contact Insight Pharmaceuticals via e-mail at [email protected], through its website at https://www.prestigebrands.com/contact, or by phone at (800) 344-7239 on Monday – Friday 8:30-5:30 eastern time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this antifungal product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0c4ee344-fe08-4e1c-9270-bf79a13d1580


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Mutuum Finance (MUTM) Raises Over $20.2M as 19,000 Investors Are Testing The V1 Protocol Launch

Global Liver Institute’s Fifth #RareAware Campaign Puts Early Detection at the Center of Care

Mutuum Finance (MUTM) Surpasses $20 Million in Funding Following Launch of Its V1 Protocol on Sepolia Testnet

Barkmeta Provides Timely Analysis on Gold and Silver Amid Market Volatility

The Jay Walker Podcast Debuts at #3 on Apple Podcasts Lifestyle Chart and #12 on iHeart Podcast Charts on Premiere Day

NOCO Healthcare’s Greeley Primary Care Redefines Community-Focused Medicine

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

In HelloNation, Insurance Expert Gregg Blanchard of Palm Beach Gardens Explains Auto Coverage Needs

TiffinStash Launches New Multi-Cuisine Taste Drives in Response to Growing Customer Demand

Editors Picks

Mutuum Finance (MUTM) Raises Over $20.2M as 19,000 Investors Are Testing The V1 Protocol Launch

February 1, 2026

Global Liver Institute’s Fifth #RareAware Campaign Puts Early Detection at the Center of Care

February 1, 2026

Mutuum Finance (MUTM) Surpasses $20 Million in Funding Following Launch of Its V1 Protocol on Sepolia Testnet

February 1, 2026

Barkmeta Provides Timely Analysis on Gold and Silver Amid Market Volatility

February 1, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Saskatchewan Roughriders face off in 2026 Winter Classic

January 31, 2026

Calgary widow turns grief into community ahead of Valentine’s Day

January 31, 2026

The Jay Walker Podcast Debuts at #3 on Apple Podcasts Lifestyle Chart and #12 on iHeart Podcast Charts on Premiere Day

January 31, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version